We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

95 hedge funds and large institutions have $80.5M invested in Mustang Bio in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 23

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

7% more capital invested

Capital invested by funds: $75.3M → $80.5M (+$5.21M)

2% more funds holding

Funds holding: 93 → 95 (+2)

0% less ownership

Funds ownership: 0.04% → 0.04% (-0%)

17% less call options, than puts

Call options by funds: $832K | Put options by funds: $1M

Holders
95
Holders Change
+2
Holders Change %
+2.15%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
34
Reduced
23
Closed
12
Calls
$832K
Puts
$1M
Net Calls
-$170K
Net Calls Change
-$647K

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$5.06M
2
JP Morgan Chase
JP Morgan Chase
New York
+$3.39M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.35M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.21M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
ECM
Endurant Capital Management
California
-$3.38M
2
Millennium Management
Millennium Management
New York
-$2.54M
3
6CM
683 Capital Management
New York
-$1.74M
4
Squarepoint
Squarepoint
New York
-$961K
5
TI
Telemetry Investments
New York
-$564K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$391K – – –
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$348K +$50.5K +17 +14%
SPC
28
Sigma Planning Corp
Michigan
$297K -$53.5K -18 -13%
Morgan Stanley
29
Morgan Stanley
New York
$290K -$172K -58 -33%
NAM
30
Nexpoint Asset Management
Texas
$282K – – –
Barclays
31
Barclays
United Kingdom
$277K +$265K +89 +405%
Ameriprise
32
Ameriprise
Minnesota
$265K +$202K +68 +179%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$258K +$190K +64 +164%
Citadel Advisors
34
Citadel Advisors
Florida
$253K -$279K -94 -48%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$253K – – –
DC
36
Davenport & Co
Virginia
$232K – – –
VF
37
Virtu Financial
New York
$227K -$473K -159 -64%
BFM
38
Boothbay Fund Management
New York
$226K – – –
Man Group
39
Man Group
United Kingdom
$223K +$268K +90 New
AG
40
Algert Global
California
$204K – – –
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
$184K +$220K +74 New
AQR Capital Management
42
AQR Capital Management
Connecticut
$168K +$199K +67 New
JF
43
Jump Financial
Illinois
$159K +$190K +64 New
Bank of America
44
Bank of America
North Carolina
$126K +$80.3K +27 +113%
FAIM
45
Financial Advocates Investment Management
Washington
$121K +$59.5K +20 +69%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$115K +$5.95K +2 +5%
QOP
47
Quinn Opportunity Partners
Virginia
$113K – – –
Deutsche Bank
48
Deutsche Bank
Germany
$109K -$11.9K -4 -8%
ECM
49
ExodusPoint Capital Management
New York
$109K +$131K +44 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$104K – – –
1
2
3 4 5

MBIO Hedge Fund Activity: Q1 2021 in Review

95 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2021, worth a combined $80.5M — up 6.9% from $75.3M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MBIO positions and 12 closed out — a net gain of 2 holders — while 34 added to existing stakes and 23 trimmed.

The largest buyer was Nuveen, adding an estimated $5.06M. The largest seller was Endurant Capital Management, exiting entirely with an estimated $3.38M sold.

  • 95 institutional investors held Mustang Bio (MBIO) as of Q1 2021, up from 93 in Q4 2020.
  • Funds reported $80.5M of Mustang Bio stock for Q1 2021, up 6.9% quarter-over-quarter.
  • 14 funds opened new Mustang Bio positions in Q1 2021 and 12 closed out, a net change of +2 holders.
  • The largest Mustang Bio buyer in Q1 2021 was Nuveen, an estimated $5.06M added.
  • The largest Mustang Bio seller in Q1 2021 was Endurant Capital Management, an estimated $3.38M sold.

Based on aggregated 13F filings for Q1 2021.